Due to the increasing number of AMI patients accompanied with a difficulty in diagnosing the anomaly, a major push to develop innovative approaches to tackle the recognition of myocardial infarctions has been noticed. Most of these advances utilize immunoassays to decrease the time of acute myocardial infarction (AMI) detection, granting the patient a better chance of survival. This article presents a technique for rapidly isolating cardiac markers from a sample solution. The paper also presents techniques to correlate the concentrations of AMI markers with detectable labels.
Journal: TechConnect Briefs
Volume: 2, Technical Proceedings of the 2006 NSTI Nanotechnology Conference and Trade Show, Volume 2
Published: May 7, 2006
Pages: 444 - 447
Industry sectors: Advanced Materials & Manufacturing | Medical & Biotech
Topics: Diagnostics & Bioimaging